Mirianas Chachisvilis

Principal investigator, leads Veriskin, Inc..

MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$7.6MFederal grants as PI9 awards
2Patents grantedLatest Nov 28, 2023
0PapersOpenAlex
Career record

Federal awards and patents by year

20162024
AwardsPatents
Federal awards as principal investigator

9 awards · $7.6M

DateAgencyAwardAmountCompany
Jul 16, 2024NIHSBIR Phase II
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics
$743KVeriskin, Inc.
Jun 21, 2023NIHSBIR Phase II
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics
$757KVeriskin, Inc.
Jul 15, 2022NIHSBIR Phase II
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics
$2.3MVeriskin, Inc.
Feb 26, 2021NIHSBIR Phase II
Clinical performance of hemodynamics-based non-invasive device for skin cancer testing
$833KVeriskin, Inc.
Mar 13, 2020NIHSBIR Phase II
Clinical performance of hemodynamics-based non-invasive device for skin cancer testing
$1.2MVeriskin, Inc.
Aug 8, 2018NIHSBIR Phase II
Hemodynamic Noninvasive Skin Cancer Diagnostics
$2KVeriskin, Inc.
May 1, 2017NIHSBIR Phase II
Hemodynamic Noninvasive Skin Cancer Diagnostics
$897KVeriskin, Inc.
Jan 18, 2017NIHSBIR Phase II
Hemodynamic Noninvasive Skin Cancer Diagnostics
$521KVeriskin, Inc.
Apr 27, 2016NIHSBIR Phase II
Hemodynamic Noninvasive Skin Cancer Diagnostics
$456KVeriskin, Inc.
Patents

3 patents as inventor

Matched by the first inventor’s name and the patent’s company.

Among 4,795 researchers in Medtech

Peer ranks

Federal funding#125
Awards as PI#166
Patents#185
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.